^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

afimoxifene

Company:
Besins Healthcare
Drug class:
Selective estrogen receptor modulator
Phase 2b
Northwestern University
Recruiting
Last update posted :
12/21/2020
Initiation :
05/31/2017
Primary completion :
07/15/2022
Completion :
07/15/2023
ER • IGF1 • CD68
|
ER positive
|
afimoxifene • Soltamox (tamoxifen citrate)